PATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.

The Journal of Pathology and Translational Medicine, published by the Korean Society of Pathologists, is a distinguished peer-reviewed Open Access journal that has been at the forefront of advancing the field of pathology and histology since its inception in 1985. With an established ISSN of 2383-7837 and an E-ISSN of 2383-7845, the journal serves as a vital platform for disseminating high-quality research, fostering collaboration among professionals and offering valuable insights into both clinical applications and theoretical advancements. Recognized for its influence in the field, it holds a commendable Q2 ranking in both Histology and Pathology & Forensic Medicine categories in 2023, and ranks #52/208 in Scopus for Medicine – Pathology and Forensic Medicine, demonstrating its impact and reach within the academic community. Located in South Korea at 1209 Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, this journal not only caters to researchers and professionals but also supports students striving to deepen their understanding of pathology. Join the growing body of knowledge and stay updated with the latest findings in this essential field of study through the journal's open access format, promoting worldwide accessibility and engagement.

HISTOPATHOLOGY is a premier scholarly journal published by WILEY, targeting the fields of histology, pathology, and forensic medicine. With an ISSN of 0309-0167 and an E-ISSN of 1365-2559, this esteemed journal has maintained a strong academic presence since its inception in 1977. Boasting an impressive Q1 ranking in crucial categories such as Histology and Pathology, it ranks 13th out of 208 in Pathology and Forensic Medicine, and 5th out of 62 in Histology, reflecting its high impact and relevance within the scientific community. HISTOPATHOLOGY serves as a critical platform for disseminating significant research findings, reviews, and advancements in the diagnostic and therapeutic aspects of pathology. Although it does not operate under an open access model, its rigorous peer-review process ensures that published articles uphold the highest standards of scientific integrity. Scholars and practitioners alike benefit from the insights shared in this journal, as it aims to bridge the gap between laboratory science and clinical practice, fostering innovation and enhancing our understanding of disease mechanisms.

npj Breast Cancer, published by NATURE PORTFOLIO, stands at the forefront of breast cancer research as an esteemed open access journal since 2015. With its impressive trajectory, the journal has garnered a notable impact within the academic community, reflecting a Q1 ranking in prestigious categories such as Oncology, Pharmacology, and Radiology for 2023. Based in the United Kingdom and indexed under E-ISSN 2374-4677, npj Breast Cancer aims to disseminate cutting-edge research that fosters innovation in prevention, diagnosis, and treatment of breast cancer, thereby addressing one of the most pressing health issues of our time. Its placement within Scopus rankings, including a remarkable 19th position in Pharmacology and a percentile ranking in the 90th range for Radiology and Oncology, highlights its significance as a key resource for researchers, healthcare professionals, and policy-makers dedicated to advancing cancer care. Emphasizing accessibility and high-quality content, npj Breast Cancer provides an influential platform for interdisciplinary collaboration and discovery in the ongoing battle against breast cancer.

Annual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.

Seminars in Diagnostic Pathology is a premier journal that has established itself as an essential resource in the field of pathology since its inception in 1984. Published by W B Saunders Co-Elsevier Inc, this journal boasts an impressive Q1 ranking in the pathology category for 2023, placing it in the top tier of medical journals worldwide. With a focus on diagnostic pathology, it offers a platform for groundbreaking research and advancements that bridge the gap between basic science and clinical practice. The journal is committed to publishing high-quality review articles, case reports, and expert opinions that provide valuable insights for professionals, researchers, and students alike. Although it operates on a subscription model, the journal's extensive impact is reflected in its Scopus rank (#56/208), with a remarkable 73rd percentile standing in the pathology and forensic medicine category. The journal's authoritative content not only aids in enhancing knowledge but also fosters an understanding of the evolving challenges and methodologies in diagnostic pathology, making it an indispensable tool for anyone dedicated to excellence in the field.

Welcome to the JOURNAL OF ORAL PATHOLOGY & MEDICINE, a distinguished publication dedicated to advancing knowledge within the realms of oral pathology and medicine. Published by WILEY since 1972, this journal has established itself as a critical resource for researchers and practitioners alike, covering a broad spectrum of topics related to oral health and disease. With an impressive array of rankings, including Q1 status in categories such as Oral Surgery and Periodontics, and a prominent position in Otorhinolaryngology, the journal is recognized for its substantial contributions to these fields. Although currently not open access, it remains pivotal in disseminating vital research findings, fostering collaboration and innovation among healthcare professionals. The interdisciplinary scope of the journal also supports its high impact factor and robust Scopus rankings, including a 92nd percentile in Otorhinolaryngology. By providing a platform for original research and reviews, the JOURNAL OF ORAL PATHOLOGY & MEDICINE plays an essential role in shaping future advancements in oral health sciences.

Virchows Archiv, published by Springer, is an esteemed journal dedicated to the fields of Medicine and Pathology, featuring high-quality research from various domains including Cell Biology and Molecular Biology. With its inception dating back to 1947, Virchows Archiv has been a pivotal platform for advancing the understanding of pathological and forensic medicine. As evidenced by its impressive Scopus rank, placing it within the top 15% of journals in Pathology and Forensic Medicine, it continues to maintain a strong presence with a Q1 classification in its category as of 2023. Although it does not offer Open Access options, the journal remains critical for researchers and professionals seeking to publish and access pioneering findings that can impact clinical practices and the academic community. The journal’s rigorous peer-review process ensures that only the highest quality research is disseminated, making it an essential resource for those engaged in the ever-evolving fields of health and biological sciences.

JCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.

Cancer Biomarkers is a leading journal in the field of cancer research, aimed at the exploration and identification of novel biomarkers for cancer detection, prognosis, and therapy. Published by IOS PRESS in the Netherlands, this journal serves as a pivotal resource for those engaged in oncology, genetics, and molecular biology, facilitating access to cutting-edge research and advancements within these disciplines. In its ongoing mission since 2005, the journal has become an essential reference point, currently occupying a Q3 category in Cancer Research, Genetics, and Oncology, and a Q2 category in miscellaneous Medicine fields. With its commitment to high-quality peer-reviewed articles, Cancer Biomarkers satisfies the intellectual appetite of researchers, clinicians, and students alike, contributing significantly to the ever-evolving landscape of cancer biomarker discovery and application. Though currently not available as Open Access, the journal maintains a robust presence in academic circles, underscored by respectable Scopus rankings across relevant categories.